SMCC-DM1

CAS No. 1228105-51-8

SMCC-DM1( DM1-SMCC )

Catalog No. M10886 CAS No. 1228105-51-8

A thioether linker conjugated with potent microtubule-disrupting agent DM1 (mertansine).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 133 Get Quote
10MG 247 Get Quote
25MG 421 Get Quote
50MG 619 Get Quote
100MG 879 Get Quote
200MG 1188 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SMCC-DM1
  • Note
    Research use only, not for human use.
  • Brief Description
    A thioether linker conjugated with potent microtubule-disrupting agent DM1 (mertansine).
  • Description
    A thioether linker conjugated with potent microtubule-disrupting agent DM1 (mertansine).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DM1-SMCC
  • Pathway
    Antibody Drug Conjugates (ADC)
  • Target
    Drug-Linker Conjugates
  • Recptor
    Drug-Linker Conjugates
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1228105-51-8
  • Formula Weight
    1072.61164
  • Molecular Formula
    C51H66ClN5O16S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C[C@@H]1[C@@H]2C[C@](NC(O2)=O)(O)[C@H](OC)/C=C\C=C(C)\CC3=CC(N(C)C(C[C@@H](OC([C@@H](N(C(CCSC(C(N4CC5CCC(C(ON6C(CCC6=O)=O)=O)CC5)=O)CC4=O)=O)C)C)=O)[C@@]7(C)C1O7)=O)=C(Cl)C(OC)=C3
  • Chemical Name
    Maytansine, N2'-deacetyl-N2'-[3-[[1-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]-2,5-dioxo-3-pyrrolidinyl]thio]-1-oxopropyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Erickson HK, et al. Cancer Res. 2006 Apr 15;66(8):4426-33. 2. Ikeda H, et al. Clin Cancer Res. 2009 Jun 15;15(12):4028-37. 3. Erickson HK, et al. Bioconjug Chem. 2010 Jan;21(1):84-92. 4. Kellogg BA, et al. Bioconjug Chem. 2011 Apr 20;22(4):717-27.
molnova catalog
related products
  • MAL-di-EG-Val-Cit-PA...

    A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.

  • Vc-MMAD

    Vc-MMAD, a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), combines the ADC linker Val-Cit (Valine-Citrulline) with the potent tubulin inhibitor MMAD.

  • SuO-Val-Cit-PAB-MMAE

    A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.